Qualigen Therapeutics Inc

NASDAQ:QLGN   3:43:40 PM EDT
0.54
+0.02 (+4.19%)
Earnings Announcements

Qualigen Therapeutics Provides Corporate Update, Reports First Quarter 2022 Financial Results

Published: 05/13/2022 11:45 GMT
Qualigen Therapeutics Inc (QLGN) - Qualigen Therapeutics, Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.12.
Q1 Revenue $700,000.
Q1 Earnings per Share View $-0.17, Revenue View $860500.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.31 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $1.46 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.